- Home
- GOOD vs ARCT Comparison
GOOD vs ARCT Comparison
Compare GOOD & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOOD | ARCT |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.4M | 526.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GOOD | ARCT |
|---|---|---|
| Price | $10.88 | $6.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $11.00 | ★ $38.67 |
| AVG Volume (30 Days) | 503.5K | ★ 913.6K |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | ★ 11.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $155,250,000.00 | $97,601,000.00 |
| Revenue This Year | $7.79 | N/A |
| Revenue Next Year | $5.12 | N/A |
| P/E Ratio | $59.52 | ★ N/A |
| Revenue Growth | ★ 4.95 | N/A |
| 52 Week Low | $10.47 | $5.85 |
| 52 Week High | $17.47 | $24.17 |
Technical Indicators
Market Signals| Indicator | GOOD | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 45.65 | 34.69 |
| Support Level | $10.47 | $6.07 |
| Resistance Level | $11.09 | $6.90 |
| Average True Range (ATR) | 0.22 | 0.42 |
| MACD | 0.03 | 0.38 |
| Stochastic Oscillator | 53.18 | 52.78 |
Price Performance
Historical ComparisonAbout GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.